Tasty&Healthy全食物饮食对无症状克罗恩病儿童及青年亚临床炎症的随机对照试验
TASTI-E随机对照试验纳入46例临床静止但黏膜炎症无创指数>8的6-40岁克罗恩病患者,比较8周Tasty&Healthy全食物饮食与常规饮食对粪钙卫蛋白的影响。15例交叉至Tasty&Healthy者在第16周钙卫蛋白<250 μg/g及黏膜炎症无创指数<8的比例均高于第8周。
要点
- Tasty&Healthy全食物饮食可降低无症状克罗恩病患者的粪钙卫蛋白水平。
- 8周干预钙卫蛋白应答率53% vs 常规饮食7%,相对风险3.23。
- 交叉后第16周钙卫蛋白<250 μg/g比例53%,黏膜炎症无创指数<8比例93%。
核心结论
- Tasty&Healthy饮食可能降低伴有亚临床炎症的克罗恩病患者的钙卫蛋白水平。
研究设计与样本
- TASTI-E为随机对照试验,纳入46例6-40岁临床静止但黏膜炎症无创指数>8的克罗恩病患者,随机分至8周Tasty&Healthy干预组(19例)或继续常规饮食组(27例),此后常规组接受8周开放标签Tasty&Healthy干预;研究因COVID-19相关困难提前终止。
主要发现
- 自我报告问卷依从性77%,粪便麸质检测依从性71%。
- 两组宏量及微量营养素摄入相似,仅Tasty&Healthy组纤维摄入更高,并出现独特的血清代谢特征。
临床怎么用
- 对于临床静止但黏膜炎症无创指数>8的克罗恩病儿童及青年,可考虑Tasty&Healthy全食物饮食以降低亚临床炎症。
- 该饮食不含配方制剂、结构灵活,可能有助于无症状个体维持较高依从性。
局限性
- 研究因COVID-19相关困难提前终止。
- 样本量较小(共46例随机)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Tasty&Healthy is an exclusive whole food diet designed to reduce inflammation in Crohn's disease without the need for formula. This TASTI-E randomized-controlled trial compared the effect of Tasty&Healthy versus habitual diet on subclinical inflammation in Crohn's disease. METHODS: Clinically quiescent patients with Crohn's disease, 6 to 40 years of age, with Mucosal Inflammation Noninvasive Index >8 reflecting bowel inflammation, were randomized to an 8-week Tasty&Healthy intervention or to continue their regular diet. Thereafter, the habitual group was offered an 8-week open-label Tasty&Healthy intervention. The primary outcome was >50% decline in calprotectin. The study was terminated early due to COVID-19-related challenges. RESULTS: Of the 46 randomized patients (mean age, 18.2 ± 7.6 years; median disease duration, 9.01 months [interquartile range, 2.9-17.1 months]), 19 were allocated to Tasty&Healthy and 27 to habitual diet. Calprotectin response was greater in the Tasty&Healthy (53%) versus habitual arm (7%; relative risk, 3.23; 95% confidence interval, 1.15-9.01; P = .028). Among 15 patients who crossed over to Tasty&Healthy, the rates of calprotectin <250 μg/g (53% vs 7%, respectively; P = .045) and Mucosal Inflammation Noninvasive Index <8 (93% versus 20%; P = .002) were higher at week 16 versus week 8. Adherence to Tasty&Healthy was 77% based on self-reported questionnaires and 71% by fecal gluten. Micronutrient and macronutrient consumption was similar between the groups, except for higher fiber intake with Tasty&Healthy. The Tasty&Healthy intervention resulted in a unique serum metabolic signature. CONCLUSIONS: The Tasty&Healthy diet may reduce calprotectin levels in patients with Crohn's disease with subclinical inflammation. Its flexible structure, free of formula, likely explains the high adherence among asymptomatic individuals. CLINICALTRIALS: gov, Number: NCT04239248.
引用
- Plotkin L, Aharoni-Frutkoff Y, Pollak D, et al. Tasty&Healthy Whole-Food Diet in Asymptomatic Children and Young Adults With Biologically Active Crohn's Disease: The TASTI-E Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2026. PMID: 42309429. doi:10.1016/j.cgh.2026.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。